Introduction
The vertebrate neuromuscular junction (NMJ) is a peripheral cholinergic synapse formed by a motor axon terminal and a skeletal muscle fiber specialization, a structure capped by terminal Schwann cells. During embryonic NMJ development, pre and postsynaptic signals regulate both the clustering of acetylcholine receptors (AChRs) on the muscle membrane and the subsequent innervation of nascent postsynaptic domains. During NMJ maturation, early post-natal elliptical postsynaptic
plaques gradually re-organize to form
pretzel-like structures, complex arrangements containing regions of high and low AChR density [
5,
46,
54]. At the ultrastructural level, AChRs concentrate at the edges of secondary folds, which are localized in direct apposition to the presynaptic active zones containing synaptic vesicle clusters and membrane proteins that allow for efficient neurotransmitter release [
71,
90]. Even though presynaptic stimulation and transmitter release are required for postsynaptic maturation at the NMJ [
54], the molecular signals controlling the architecture of functional mature NMJs have not been fully elucidated.
Neurotrophins (NTs) are a family of growth factors that play a wide variety of functions in the nervous system through their binding to and activation of specific tyrosine kinase receptors (Trks) [
10]. Effects on neuronal survival and neuronal growth are mainly triggered by binding of the nerve growth factor (NGF) to TrkA, the brain-derived neurotrophic factor (BDNF) and NT-4 to TrkB, and the NT-3 to TrkC [
11,
33]. In addition, all NTs and their non-processed forms (pro-NTs) bind to the pan-NT receptor p75 (p75
NTR), a multifunctional signaling receptor that belongs to the tumor necrosis factor receptor family [
10]. Inhibition of axonal pruning, long-term depression and developmental or injury-induced apoptosis mainly rely on the binding of NTs and pro-NTs to p75
NTR [
22,
85,
93].
While p75
NTR is widely expressed in different neuronal and glial populations in the developing nervous system, its expression is down-regulated towards adulthood [
57,
95]. All three NMJ cellular components retain low p75
NTR expression levels at adult stages [
25‐
27]. Even though p75
NTR null mice (p75
NTR−/−) display delayed NMJ synaptic refinement during early post-natal development, these phenotypes become soon restored [
37]. Remarkably, p75
NTR is strongly re-expressed in motor neurons and Schwann cells in conditions that negatively affect the nervous system [
35]. These include experimental paradigms of nerve injury [
39,
65,
79,
89,
91] and of amyotrophic lateral sclerosis [
41,
52,
72], a neurodegenerative disease characterized by NMJ disruption and subsequent motor neuron death [
59]. Cumulative evidence has demonstrated that p75
NTR up-regulation impairs nervous system repair [
2,
20,
35,
79,
88] and, consistently, p75
NTR targeting has emerged as a therapeutic alternative to delay damage or disease progression [
56,
74,
81]. Even though the aforementioned evidence reveals that p75
NTR targeting could be beneficial for nerve repair, the effects of chronic p75
NTR inhibition at the mature neuromuscular synapse have not been deeply analyzed.
Our goal was to perform in-depth neuroanathomical and neurophysiological analyses of the NMJ of p75
NTR−/− mice [
48]. In these mice, we found altered NMJ morphology, evidenced by decreased size and aberrant postsynaptic organization. These phenotypes were accompanied by increased muscle fatigability after presynaptic stimulation, reduced muscle fiber size and locomotor defects. Also, p75
NTR−/− mice display a reduced number of synaptic vesicles in motor axon terminals. Functional experiments showed that acetylcholinesterase inhibition rescued nerve-evoked muscle response and force production. Together, these studies reveal that the absence of p75
NTR negatively affects NMJ neurotransmission, which correlates with impaired morphology and function of the neuromuscular synapse.
Discussion
Dysfunctions of the NMJ are caused by traumatic spinal cord or peripheral nerve injuries as well as by severe motor pathologies [
35,
36,
59]. Despite the remarkable regenerating ability of the peripheral nervous system, delayed NMJ regeneration paradigms show that, even though muscles are reached by motor axons and re-build morphologically normal NMJs after long-term denervation, regeneration after a critical period is not associated with a positive functional outcome in distal muscles [
53,
70], suggesting synaptic rather than regenerative failures after critical periods of time. In mice models of amyotrophic lateral sclerosis, it has been demonstrated that NMJ disruption precedes subsequent motor neuron death [
59], demonstrating a critical primary role for NMJ maintenance in the etiology of this neurodegenerative disease. Together, these findings reveal that cells at the damaged NMJ niche express signals that impair synaptic maintenance and repair [
78]. Cumulative evidence shows that p75
NTR is likely one such molecule. Although Schwann cell-derived p75
NTR plays a major role on the perinatal elimination of muscle fiber poly-innervation [
37,
92], NMJs of P14 p75
NTR−/− mice showed no evident alterations regarding AChR clustering and their innervation profile [
37], suggesting a minor function for this receptor on the maintenance and function of mature NMJs. Remarkably, various experimental paradigms of nerve injury result in strongly increased p75
NTR expression in motor neurons [
19,
42,
69] and Schwann cells [
30,
65,
79]. Also, p75
NTR expression is up-regulated in spinal cord motor neurons in mice models of amyotrophic lateral sclerosis [
41,
52,
72]. Rather than a positive outcome given by its role as a receptor for NTs, cumulative evidence has demonstrated that p75
NTR up-regulation impairs nervous system repair, a feature related to its additional role as a cell death mediator in various neuronal and glial populations [
1,
8,
20‐
22]. Indeed, p75
NTR inhibition has been successfully tested as a pharmacological target to delay disease progression [
35,
74], and chronic administration of a p75
NTR antisense peptide nucleic acid [
81] or a p75
NTR-derived trophic cell-permeable peptide delays motor dysfunction and mortality in amyotrophic lateral sclerosis mice models [
56]. Despite this evidence, the outcome of chronic p75
NTR inhibition on the maintenance of mature NMJs has not been studied. Therefore, we aimed to deeply characterize, using neuroanatomical and neurophysiological tools, the structure and function of p75
NTR−/− mice NMJs. Our finding show that the absence of p75
NTR impairs postsynaptic organization and ultrastructural complexity of the NMJ, which correlate with altered synaptic function at the levels of nerve activity-induced muscle responses, muscle fiber structure, force production, and locomotor performance.
Our studies provide the first evidence that chronic p75
NTR deficiency results in aberrant NMJ maturation accompanied by altered pre- and post-synaptic structure and defective neurotransmission. We found that the absence of p75
NTR results in a significant reduction in the number of synaptic vesicles and active zones, as well as in the density of the RRP of vesicles, supporting the idea that a reduction in ACh release could account for the observed motor phenotypes in p75
NTR−/− mice. Our results also reveal defects in postsynaptic complexity at the NMJ of p75−/− mice, evidenced by a reduced number of secondary folds, i.e. the membrane postsynaptic structures that increase the postsynaptic area and concentrate both, AChRs and the voltage-gated sodium channel Nav1.4, thus favoring action potential generation for subsequent muscle contraction [
76,
77,
94]. As a morphological support of the defects observed in both, pre and postsynaptic domains, the use of an AChE inhibitor drug resulted in the recovery of NMJ synaptic transmission and muscle strength in p75
NTR−/− mice. Consistent with our findings, presynaptic motor terminals are required for postsynaptic maturation, as muscle denervation at P10 halts subsequent postsynaptic plaque-to-pretzel transition [
54]. Our results also show a significant alteration in motor coordination and balance in p75
NTR−/− mice, as previously reported [
64,
68,
96]. In this context, mice null for p75
NTR in the cerebellar external granular layer (EGL) also display altered motor performance [
96]. Additionally, it has been shown that the absence of p75
NTR in hippocampal neurons reduces neurogenesis, resulting in some behavioral alterations but, interestingly, not in locomotor defects [
9,
12]. Our studies provide novel evidence showing that, in addition to its effects on the central motor coordination, the absence of p75
NTR specifically alters NMJ pre- and postsynaptic organization, a feature that can at least partially explain the observed defects in muscle structure and locomotor performance.
The mouse model used throughout our studies express a p75
NTR isoform lacking cysteine repeats 2, 3, and 4 and express a truncated form of p75
NTR receptor that could potentially contribute to the phenotypes that we and others have described in these mice [
86]. However, polypeptide fragments derived from this truncated form of p75
NTR are expressed at low levels, as they are susceptible to degradation by the α- and γ-secretases, as well as by the proteasome system; indeed, Trk-dependent signaling activates the α-secretase processing and endosomal targeting of these p75
NTR-derived fragments [
83]. If any, the p75
NTR protein fragments expressed by p75
NTR exon III null mice could play a beneficial effect in the context of the NMJ, as they have been shown to increase BDNF-TrkB dependent survival of motor neurons in vitro and in vivo in the hSODG93A mice model of amyotrophic lateral sclerosis [
56]. Therefore, future experiments using complete p75
NTR null models will complement our observations regarding the critical effects that p75
NTR inhibition exerts in the organization of mature NMJs.
Our functional studies showed that repetitive presynaptic stimulation resulted in increased muscle fatigability, as well as in impaired muscle force generation and CMAP values in p75
NTR−/− mice. Interestingly, we observed a rescue of a single CMAP value in p75
NTR−/− mice 7 s after repetitive nerve stimulation. A comparative protocol is commonly used in the clinic to discriminate the pre or postsynaptic etiology of myasthenic diseases; CMAP values at rest are reduced but display a strong rescue 10 s after maximal voluntary contraction (MVC) in myasthenic diseases of presynaptic origin (such as the Lambert-Eaton myasthenic syndrome) due to post-activation facilitation (PAF) [
49]. Also, while acetylcholinesterase inhibition increased CMAP values at days 1 and 3, this effect was lost at day 5, a finding consistent with the observation that sustained administration of cholinesterase inhibitors as a monotherapy are minimal and not sustained in time in presynaptic myasthenic diseases [
84]. Therefore, despite the limitations of our approach to be compared to the clinical practice, and although a postsynaptic effect cannot be discarded, we believe that our electromyographic recordings, along with the transmission electron microscopy studies, strongly suggest a main presynaptic defect at the NMJ of p75
NTR−/− mice. We speculate that this sustained upstream presynaptic defect impairs neurotransmitter availability, which is manifested in downstream defects in NMJ morphology, muscle fiber structure, and locomotor performance.
p75
NTR is a multifaceted receptor with the ability to signal through NT-dependent and independent pathways. Even though our results suggest that BDNF/TrkB signaling is not significantly affected at the NMJ of p75
NTR−/− mice, several lines of evidence relate NT signaling with the defects we found in these mice. For instance, acute antibody-dependent blocking of p75
NTR impairs ACh release in immature and mature neuromuscular synapses via a BDNF/TrkB-dependent mechanisms that regulates the phosphorylation of presynaptic proteins [
24,
27,
62,
75]. Our findings showing that the availability of synaptic vesicles is severely compromised in the absence of p75
NTR are also related to NT signaling. Indeed, decreased expression of integral synaptic vesicle proteins has been reported in cultures of neurons derived from conditions with altered NT-dependent signaling, such as TrkB, TrkC and BDNF deficient mice [
18,
55,
67,
80]. In addition, NTs have been reported to be involved in synaptic vesicle fusion to the plasma membrane in nerve terminals of central synapses [
55,
67,
80,
82]. In frog nerve-muscle co-cultures, the expression of synapsin I, a presynaptic protein that distributes in myotube-contacting neurites, is increased by NT3 [
87]. Interestingly, similar to our findings in the p75
NTR null mice, NT3+/− mice exhibit impaired muscle contraction force and lower synaptic vesicle recycling in motor axon terminals [
73]. We also found that p75
NTR−/− mice displayed increased susceptibility to fatigue after tetanic nerve stimulation, a phenotype similar to that observed in NT4−/− mice [
3]. The idea that Trk receptors and p75
NTR exert comparable effects at the NMJ is also supported by the functional consequences of reducing TrkB and p75
NTR. Indeed, heterozygous TrkB+/− mice show decreased contractile force and muscle fiber CSA [
44], as we found in p75
NTR−/− mice. In turn, activation of TrkB signaling in mice null for TrkB.t1, an endogenous truncated dominant-negative variant of the receptor, results in increased isometric contraction force and increased CSA [
17], exactly opposite to what we found in p75
NTR−/− mice. An interesting comparison also emerges regarding TrkB and p75
NTR inhibition in a pathological context. Indeed, inhibition of TrkB expression in motor neurons of an amyotrophic lateral sclerosis mice model results in beneficial delaying effects on disease progression [
97], whereas TrkB deletion impairs NMJ structure and function [
28,
44]. Together with our findings, these results reveal the need for future research to elucidate how Trk and p75
NTR receptors act at the mature NMJ and how the signaling pathways controlled by these receptors are balanced to contribute to the correct apposition between the nerve terminal and the post-synaptic muscle domain. Our findings also contribute to a more comprehensive view of the effects that therapeutic attempts to target p75
NTR may have at the neuromuscular connectivity.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.